IntroductionIslamHeritageScienceEnvironmentTechnologyHealth an Islamic PerspectiveEthicsBioethicsBiographyPsychologyEncyclopediaMuslim ScientistsAbout the Organization IOMSSeminars and ConferencesHealth NewsPublicationsMedical NewsArabicBreaking NewsE-mailSitemapQuestion and Answers

<Home> <Newsletter> <Second Issue> <Genetic Engineering> <More cloning but still no stem cells>

Main Topic: C) GENETIC ENGINEERING

More cloning but still no stem cells

 

According to Jesse Reynolds' article, (Project Director on Biotechnology Accountability at the Centre for Genetics and Society) posted on February 12th, 2009 in Biopolitical Times. In the last two months, three teams of researchers have created human clonal embryos and before them only the researchers at the biotech company Stemagen had reported creating a human embryo via somatic cell nuclear transfer (SCNT) that appeared to be viable enough to potentially yield stem cells. However, none of the groups reported taking that step.

The Stemagen paper described how human eggs necessary for SCNT were obtained, but none of the three recent papers mentioned where or how thy got eggs, or how the women who provided them were treated. Were the women paid? Were they undergoing egg extraction for reproductive purposes, or just for research? How old were they? And how were they recruited?

Two of the new papers, both from Chinese teams, simply describe their successful method of creating the clonal embryos. Only the paper by the group led by

Robert Lanza of the biotech company Advanced Cell Technology goes one step further, comparing the epigenomics of clonal embryos that were created using human eggs with those created using animal eggs, and it indicated that the clonal embryos created using animal eggs "cytoplasmic hybrid embryos" may not yield useful stem cells, as their epigenetic characteristics are significantly different from those created with human eggs.

Some may conclude that women's eggs are therefore necessary for cloning-based stem cell research. Other scientists are moving away from cloning techniques altogether. Alan Trounson, president of the California Institute for Regenerative Medicine said that working with human embryos is impractical because the high failure rate means it takes hundreds of eggs to create a single stem cell line. He added that most people are working on IPS (induced pluripotent cells) rather than the nuclear transfer because it is so difficult to get human eggs.

More information could be found at:
www.biopoliticaltimes.org/article.php?id=4524

       
     
IOMS Newsletter - 12 August 2009  
Issue No. 002/09
 
 
Back to Main Page Back to Main Page (Contents)
First Issue
 

 

Islamset Website